We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




iCAD Comments on Recent CAD, Mammography Study

By MedImaging staff writers
Posted on 23 Apr 2007
iCAD, Inc. More...
(Nashua, NH, USA), an industry-leading provider of computer-aided detection (CAD) systems for the early identification of cancer, commented on a study published in the April 5, 2007, issue of the New England Journal of Medicine (NEJM) entitled, "Influence of Computer-Aided Detection on Performance of Screening.”

CAD uses advanced algorithms to identify areas of interest on a mammography film, acting as a "second set of eyes” for the radiologist. The researchers of the recent NEJM study concluded that the use of CAD is "associated with reduced accuracy of interpretation of screening mammograms. The increased rate of biopsy with the use of computer-aided detection is not clearly associated with improved detection of invasive breast cancer.”

In response to that article, iCAD stated that numerous peer-reviewed published studies confirm that CAD technology finds more tumors earlier, a point that remains undisputed. The company noted that the authors of this study assessed results from the use of older versions of CAD software released to the market five to nine years ago. Over the last several years, there have been considerable developments made to CAD technology, and more specifically, in its sensitivity to finding cancer and reducing false-positives. Additionally in that time, more than 25 published studies evaluating CAD technology have demonstrated the benefits of the technology in improving the detection of cancer, according to iCAD.


Related Links:
iCAD

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Fetal Monitor
BT-380
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.